MitoAction Expert Series

Reneo Pharmaceuticals LC-FAOD REN001 Clinical Trial Update


Listen Later

There was much discussion about current research in FAODs at our recent International Metabolic conference last month. Reneo Pharmaceuticals recently released positive results from the REN001 Phase1b LC-FAOD Study.

...more
View all episodesView all episodes
Download on the App Store

MitoAction Expert SeriesBy MitoAction

  • 4.4
  • 4.4
  • 4.4
  • 4.4
  • 4.4

4.4

24 ratings